{"id":"https://openalex.org/W4282961367","doi":"https://doi.org/10.1158/1538-7445.am2022-302","title":"Abstract 302: MEKi-FGFRi combination nanoparticles for use against KRASmt/FGFR-compensatory lung tumors","display_name":"Abstract 302: MEKi-FGFRi combination nanoparticles for use against KRASmt/FGFR-compensatory lung tumors","publication_year":2022,"publication_date":"2022-06-15","ids":{"openalex":"https://openalex.org/W4282961367","doi":"https://doi.org/10.1158/1538-7445.am2022-302"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2022-302","doi":"https://doi.org/10.1158/1538-7445.am2022-302","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2022-302","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5036271848","display_name":"Arianna R. Izawa-Ishiguro","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Arianna R. Izawa-Ishiguro","raw_affiliation_strings":["1Memorial Sloan Kettering Cancer Center, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Memorial Sloan Kettering Cancer Center, New York, NY","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042860091","display_name":"Ramya Sridharan","orcid":"https://orcid.org/0000-0003-0235-6396","observed_orcids":["https://orcid.org/0000-0003-0235-6396"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ramya Sridharan","raw_affiliation_strings":["1Memorial Sloan Kettering Cancer Center, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Memorial Sloan Kettering Cancer Center, New York, NY","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020842299","display_name":"Christopher Wun","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Christopher Wun","raw_affiliation_strings":["1Memorial Sloan Kettering Cancer Center, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Memorial Sloan Kettering Cancer Center, New York, NY","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077635855","display_name":"Tabassum J. Sami","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tabassum J. Sami","raw_affiliation_strings":["1Memorial Sloan Kettering Cancer Center, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Memorial Sloan Kettering Cancer Center, New York, NY","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5037355958","display_name":"Daniel A. Heller","orcid":"https://orcid.org/0000-0002-6866-0000","observed_orcids":["https://orcid.org/0000-0002-6866-0000"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Daniel A. Heller","raw_affiliation_strings":["1Memorial Sloan Kettering Cancer Center, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Memorial Sloan Kettering Cancer Center, New York, NY","institution_ids":["https://openalex.org/I1334819555"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I1334819555"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"82","issue":"12_Supplement","first_page":"302","last_page":"302"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.986299991607666,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.986299991607666,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":0.0034000000450760126,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10725","display_name":"RNA Interference and Gene Delivery","score":0.0024999999441206455,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/kras-mutant-lung-cancer","display_name":"KRAS-mutant lung cancer","score":0.9340000152587891},{"id":"https://openalex.org/keywords/trametinib","display_name":"trametinib","score":0.8560000061988831},{"id":"https://openalex.org/keywords/mek-inhibitors","display_name":"MEK inhibitors","score":0.7749999761581421},{"id":"https://openalex.org/keywords/fgfr1-inhibition","display_name":"FGFR1 inhibition","score":0.8420000076293945},{"id":"https://openalex.org/keywords/ponatinib","display_name":"ponatinib","score":0.968999981880188},{"id":"https://openalex.org/keywords/mapk-pathway-reactivation","display_name":"MAPK pathway reactivation","score":0.6909999847412109},{"id":"https://openalex.org/keywords/compensatory-signaling","display_name":"compensatory signaling","score":0.8230000138282776},{"id":"https://openalex.org/keywords/targeted-drug-delivery","display_name":"targeted drug delivery","score":0.6129999756813049},{"id":"https://openalex.org/keywords/lung-cancer","display_name":"lung cancer","score":0.46299999952316284}],"concepts":[{"id":"https://openalex.org/C2778472372","wikidata":"https://www.wikidata.org/wiki/Q7833138","display_name":"Trametinib","level":4,"score":0.945461630821228},{"id":"https://openalex.org/C2780381907","wikidata":"https://www.wikidata.org/wiki/Q198728","display_name":"Ponatinib","level":5,"score":0.8139230012893677},{"id":"https://openalex.org/C2781249067","wikidata":"https://www.wikidata.org/wiki/Q17142288","display_name":"MEK inhibitor","level":4,"score":0.7565587162971497},{"id":"https://openalex.org/C49418065","wikidata":"https://www.wikidata.org/wiki/Q14914258","display_name":"Fibroblast growth factor receptor 1","level":4,"score":0.6760004758834839},{"id":"https://openalex.org/C57074206","wikidata":"https://www.wikidata.org/wiki/Q14197552","display_name":"MAPK/ERK pathway","level":3,"score":0.6330620646476746},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6146937608718872},{"id":"https://openalex.org/C82867764","wikidata":"https://www.wikidata.org/wiki/Q24780051","display_name":"Fibroblast growth factor receptor","level":4,"score":0.5173937082290649},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.44700127840042114},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.435772567987442},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.42019781470298767},{"id":"https://openalex.org/C2781187634","wikidata":"https://www.wikidata.org/wiki/Q20969980","display_name":"KRAS","level":4,"score":0.4110053777694702},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3804187774658203},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.37790828943252563},{"id":"https://openalex.org/C74373430","wikidata":"https://www.wikidata.org/wiki/Q24727126","display_name":"Fibroblast growth factor","level":3,"score":0.3303545117378235},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.23340779542922974},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.22764131426811218},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.21787220239639282},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.1713450849056244},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.13591134548187256},{"id":"https://openalex.org/C2779536868","wikidata":"https://www.wikidata.org/wiki/Q419940","display_name":"Dasatinib","level":4,"score":0.10926291346549988},{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.0},{"id":"https://openalex.org/C2777583451","wikidata":"https://www.wikidata.org/wiki/Q177094","display_name":"Imatinib","level":3,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2022-302","doi":"https://doi.org/10.1158/1538-7445.am2022-302","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2022-302","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.98580002784729,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2474854223","https://openalex.org/W2499183659","https://openalex.org/W2470024294","https://openalex.org/W3217058086","https://openalex.org/W2208494337","https://openalex.org/W2797525132","https://openalex.org/W2902072671","https://openalex.org/W3083363429","https://openalex.org/W2346079527","https://openalex.org/W4245061930"],"abstract_inverted_index":{"Abstract":[0],"Targeting":[1],"oncogenic":[2],"signaling":[3],"in":[4,24,31,206],"the":[5,127,238],"MAPK":[6,33,154],"pathway":[7,34,155],"can":[8,159,171,197],"be":[9,160,172,198],"achieved":[10],"with":[11,46,108,139],"small":[12],"molecules":[13],"such":[14],"as":[15],"trametinib,":[16],"a":[17,109,140],"MEK":[18,22,44],"inhibitor":[19,72,95,169],"(MEKi).":[20],"Trametinib-induced":[21],"inhibition":[23,45,48],"KRAS-mutant":[25],"(KRASmt)":[26],"lung":[27,134,176,232],"cancer,":[28],"however,":[29],"results":[30],"compensatory":[32,153],"re-activation":[35],"through":[36,157],"fibroblast":[37],"growth":[38,100,203],"factor":[39],"receptor":[40],"1":[41],"(FGFR1).":[42],"Combining":[43],"FGFR1":[47,158],"should":[49],"thereby":[50],"combat":[51],"this":[52],"compensation;":[53],"nonetheless,":[54],"systemic":[55,186],"administration":[56],"of":[57,64,103,111,142,167,237],"combination":[58,89,195,226],"therapy":[59,90],"faces":[60],"its":[61,116],"own":[62],"set":[63],"challenges.":[65],"Such":[66],"challenges":[67],"include":[68],"delivering":[69],"appropriate":[70],"kinase":[71,168],"concentrations":[73,166],"to":[74,123,145,175,200],"target":[75,132],"tumor":[76],"tissue":[77],"while":[78,178],"avoiding":[79],"dose-limiting":[80],"additive":[81],"toxicities.":[82],"Although":[83],"previous":[84],"work":[85],"has":[86],"identified":[87],"that":[88,183,192],"involving":[91],"trametinib":[92,138],"and":[93,101,113,204],"FGFR":[94],"(FGFRi)":[96],"ponatinib":[97,106],"synergistically":[98],"inhibits":[99],"proliferation":[102,205],"KRASmt":[104],"cells,":[105],"interacts":[107],"variety":[110,141],"targets":[112],"may":[114],"mediate":[115],"synergistic":[117],"effects":[118,182],"via":[119],"mechanisms":[120],"not":[121],"specific":[122],"FGFR1.":[124],"To":[125],"improve":[126],"efficacy":[128],"at":[129],"which":[130],"we":[131,136,190],"KRASmt/FGFR-compensatory":[133,207,231],"tumors,":[135],"encapsulated":[137],"FGFR1-specific":[143],"inhibitors":[144],"form":[146],"P-selectin-targeted":[147],"nanoparticles.":[148],"By":[149],"formulating":[150],"these":[151,193],"nanoparticles,":[152],"activation":[156],"more":[161],"efficaciously":[162,201],"inhibited.":[163],"Concurrently,":[164],"greater":[165],"combinations":[170],"locally":[173],"delivered":[174],"tumors":[177,233],"mitigating":[179],"toxic":[180],"side":[181],"occur":[184],"from":[185],"free":[187],"drug.":[188],"Here":[189],"show":[191],"MEKi-FGFRi":[194,225],"nanoparticles":[196,227],"formulated":[199],"inhibit":[202],"cancer":[208],"cells.":[209],"Citation":[210],"Format:":[211],"Arianna":[212],"R.":[213],"Izawa-Ishiguro,":[214],"Ramya":[215],"Sridharan,":[216],"Christopher":[217],"Wun,":[218],"Tabassum":[219],"J.":[220],"Sami,":[221],"Daniel":[222],"A.":[223],"Heller.":[224],"for":[228,241],"use":[229],"against":[230],"[abstract].":[234],"In:":[235],"Proceedings":[236],"American":[239],"Association":[240],"Cancer":[242,253],"Research":[243],"Annual":[244],"Meeting":[245],"2022;":[246],"2022":[247],"Apr":[248],"8-13.":[249],"Philadelphia":[250],"(PA):":[251],"AACR;":[252],"Res":[254],"2022;82(12_Suppl):Abstract":[255],"nr":[256],"302.":[257]},"counts_by_year":[{"year":2024,"cited_by_count":1}],"updated_date":"2026-10-08T09:06:37.294493","created_date":"2022-06-17T00:00:00"}